Cellceutix is pleased to announced a new clinical

Cellceutix is pleased to announced a new clinical trial for our very novel wonder-drug Kevetrin. The Phase 1 trials are to be held at a prestigious hospital in Ireland with an unidentified big pharma, for which we have an iron-clad non-disclosure agreement (Andrew doesn't even know!) Kevetrin will be combined with Guinness as a cocktail to prevent over-excitement and hyper anxiety for those individuals waiting for the CTIX Party to be held once the stock explodes! FDA approval is expected once the trials are designated for fast track and orphan drug status!